亚太地区药品定价和报销方法研究  

Research of Drug Pricing and Reimbursement Methods in Asia

作　　者：赵帅 吴睿[2] 杨柳 孙涛林 朱刚令 无 Zhao Shuai;Wu Rui;Yang Liu;Sun Taolin;Zhu Gangling(The Army Logistics Academy of PLA,Chongqing,401311,China;不详)

机构地区：[1]陆军勤务学院,重庆401311 [2]海南医学院管理学院,海口571199 [3]陆军军医大学第九五八医院,重庆400038 [4]重庆药品交易所股份有限公司,重庆400030

出　　处：《中国卫生经济》2023年第12期57-60,共4页Chinese Health Economics

基　　金：重庆市科卫联合项目(2022QNXM033);海南医学院校级科研课题(HYPY201929)。

摘　　要：目的:系统梳理亚洲地区药品定价和报销方法及应用情况,为我国药品定价政策提供借鉴和参考。方法:检索亚洲地区药品定价相关文献,并通过对应国家的网站,筛选、提取、汇总药品定价的相关政策、方法、执行方式和应用效果等相关信息。结果:共有7种药品定价方法(内部参考定价、外部参考定价、特殊协议定价、药物经济学评估、成本加权定价、招标和谈判、价格维持溢价)在亚洲地区作为关键策略广泛应用,各国家均同时采用多种药品定价方法,执行方法也存在较大差异。结论:在增加医疗保健可及性、控制医药成本、激发新药研发等多重要求情况下,多种药品定价方法并行是必要且可行的,不同的政策执行方式也会产生完全不同的应用效果。Objective:Systematically review drug pricing and reimbursement strategies,methods and applications in Asia to pro-vide references for drug pricing and reimbursement policy-making in China.Methods:Retrieval and screen literatures related to drug pricing policies,methods,implementation and application effects through documentary library and websites of corresponding countries.Results:A total of 7 drug pricing methods(internal reference pricing,external reference pricing,special agreement pricing,pharmacoeconomic evaluation,cost-weighted pricing,price maintenance premium,bidding and negotiation)were widely used as key strategies in Asia.Various drug pricing methods were used in different countries and the implementation methods were quite different.Conclusion:In the case of medical care accessibility,cost controlling and stimulating the creativity,it is necessary and feasible to have multiple drug pricing methods.The application effects were also difference due to the different policy implementation.

关 键 词：亚洲地区 药品定价 定价方法 药品报销 

分 类 号：R956[医药卫生—药学]